Is ohi a strong buy?

Omega Healthcare Investors (OHI) is not a strong buy at this time. Here's the analysis to support this conclusion:

1. Analyst Ratings and Price Targets: The consensus among analysts is to hold OHI shares, with a price target of $33.67, which represents a potential downside of 7.93% from the last closing price of $37.99. This suggests that analysts believe the stock is fairly valued but do not indicate a strong buy.
2. Recent Performance: OHI has increased by 24.67% over the past quarter and has gained 20.92% in the last year. However, the stock has a 50-day simple moving average of $37.72 and a 200-day simple moving average of $37.66, which are below the current price, indicating a potential for a pullback.
3. Financial Health: The company has a debt-to-equity ratio of 1.19, which is relatively low, and a free cash flow of $286.29 million, indicating financial stability. However, the return on equity is not provided, which is a key metric for assessing the efficiency of equity investments.
4. Dividend: OHI offers a dividend yield of 9.21%, which is attractive for income-focused investors. However, the dividend payout ratio is not provided, which is necessary to evaluate the sustainability of the dividend.

In conclusion, while OHI has shown strong performance in the past, the current analyst consensus and valuation metrics suggest that it is not a strong buy at this time. Investors should consider their investment horizon and risk tolerance before making a decision.